Consensus statement: Management of drug-induced liver injury in HIV-positive patients treated for TB

Southern African Journal of HIV Medicine

 
 
Field Value
 
Title Consensus statement: Management of drug-induced liver injury in HIV-positive patients treated for TB
 
Creator Jong, E Conradie, F Berhanu, R Black, A John, M-A Meintjes, G Menezes, C
 
Subject drug-induced liver injury; ART; TB treatment
Description Drug-induced liver injury (DILI) in HIV/tuberculosis (TB) co-infected patients is a common problem in the South African setting, and re-introduction of anti-TB drugs can be challenging for the healthcare worker. Although international guidelines on the re-introduction of TB treatment are available, the definition of DILI is not uniform, management of antiretroviral therapy (ART) in HIV co-infection is not mentioned, and the guidance on management is not uniform and lacks a practical approach. In this consensus statement, we summarise important aspects of DILI and provide practical guidance for healthcare workers for different patient groups and healthcare settings on the re-introduction of anti-TB drugs and ART in HIV/TB co-infected individuals presenting with DILI.
 
Publisher AOSIS
 
Date 2013-09-17
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion —
Format text/html application/pdf
Identifier 10.4102/sajhivmed.v14i3.63
 
Source Southern African Journal of HIV Medicine; Vol 14, No 3 (2013); 113-119 2078-6751 1608-9693
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://sajhivmed.org.za/index.php/hivmed/article/view/63/93 https://sajhivmed.org.za/index.php/hivmed/article/view/63/92
 
Rights Copyright (c) 2013 E Jong, F Conradie, R Berhanu, A Black, M-A John, G Meintjes, C Menezes https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT